Competition & Markets Authority
CMA secures changes from major PCR testing provider
UK PCR testing provider Randox has improved its terms on cancellations, refunds and liability, following discussions with the CMA.
As part of its ongoing engagement in the PCR tests sector, the Competition and Markets Authority (CMA) raised concerns with Randox – one of the largest providers in the sector – about some of its terms and conditions.
As a result, Randox has now reviewed its terms and conditions and has changed them to:
- Give clearer information to customers, in particular on when it will provide PCR tests and results
- Improve notification of customers’ legal rights on cancellations and refunds, for example making it clear they have a right to a ‘cooling off’ period
- Remove terms that could suggest customers aren’t entitled to compensation if things go wrong
Andrea Coscelli, Chief Executive of the CMA, said:
With recent changes to the rules for travel, the spotlight is once again on PCR testing providers and their practices.
I am pleased that Randox has agreed to change its terms, which means consumers benefit from their legal rights to cancel and get a refund, and are not stopped from pursuing compensation if there is a problem. However, it’s essential that all companies play by the rules and treat people fairly. We are clear that, if they fail to do so, they risk facing enforcement action from the CMA or Trading Standards.
We recently provided recommendations to government on changes to better protect consumers in this market and we hope that, given the reintroduction of PCR testing for travellers, these will be implemented as quickly as possible.
The CMA’s engagement with Randox is part of a wider set of actions the CMA has taken to protect consumers in this market. In August 2021, the CMA published an open letter to PCR providers, outlining how they should comply with consumer law. Practices of concern included:
- Advertising up-front prices for PCR tests which do not include additional charges
- Advertising cheap PCR tests which are only actually available in very small quantities or not at all
- Failing to deliver PCR tests or provide results within stated timescales
- Refusing to provide people with refunds where tests are not provided within advertised or agreed timescales
The CMA has also sent letters to 25 PCR providers, warning them to review their terms and conditions – and other practices - or risk facing enforcement action. It currently has formal investigations open into 2 PCR providers, Expert Medicals and Dante Labs.
In addition, the CMA has provided advice to the UK Government on ways to make the PCR testing market work better for consumers. The recommendations included improving the basic standards to qualify for inclusion and remain on the GOV.UK list; monitoring providers on this list and swiftly removing, and sanctioning, those firms that don’t meet these standards; and adding information to enable consumers to compare providers properly and find the best deals for them.
Notes to editors
- Randox Health London Ltd, is a company registered in England under company number 9102173 with registered office at 5 Finsbury House, 23 Finsbury Circus, London, EC2M 7EA. Randox Health London Ltd is a private provider of COVID 19 testing services. Randox Health London Ltd appoint their partner laboratory Randox Laboratories Limited to perform the testing and t/as RCLS, a company registered in Northern Ireland under company number NI015738, whose registered office address is Ardmore, 55 Diamond Road, Crumlin, Co. Antrim, BT29 4QY
- For media queries, please contact the press office via email@example.com or on 020 3738 6460.
Latest News from
Competition & Markets Authority
In-depth Veolia-Suez merger review finds competition concerns19/05/2022 12:20:00
The CMA has provisionally found that the merger of Veolia and Suez would lead to a loss of competition in the supply of several waste and water management services in the UK.
Property search services merger could mean homebuyers pay more18/05/2022 12:25:00
The CMA has provisionally found that the merger of 2 firms offering property search services could lead to a worse deal for homebuyers.
Cartels exploiting cost-of-living crisis will face action, warns CMA13/05/2022 12:20:00
The CMA’s most senior enforcer has warned that anyone looking to exploit the cost-of-living crisis by forming cartels risk robust enforcement action, including possible dawn raids.
Michael Grenfell: The CMA in turbulent times - where we are and where we're going11/05/2022 10:10:10
A speech delivered by Michael Grenfell, Executive Director of Enforcement at the CMA, at the Pinsent Masons annual competition conference.
CMA publishes code of conduct advice for platforms and publishers09/05/2022 12:20:00
Big tech companies should agree fairer deals with online publishers in order to use their content, according to the UK’s competition watchdog.
LSEG’s anticipated Quantile purchase raises competition concerns05/05/2022 12:20:00
LSEG’s anticipated purchase of Quantile could now be referred for an in-depth investigation after finding that the deal raises competition concerns.
CMA cancels investigation after Ritchie Bros and Euro Auctions abandon merger04/05/2022 12:10:00
Ritchie Bros has abandoned its planned purchase of Euro Auctions after the CMA referred the deal for an in-depth Phase 2 investigation.
Petrol station proposals provisionally clear way for Morrisons deal04/05/2022 11:10:00
The CMA proposes to accept an offer from buyer of Morrisons to sell 87 petrol stations to address competition concerns.